Ketoblink 200 Tablet contains Ketoconazole 200 mg, an antifungal agent used primarily for the treatment of various fungal infections. Ketoconazole belongs to the imidazole class of antifungals and functions by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This medication is indicated for the management of systemic and superficial mycoses, including candidiasis, dermatophytosis, and seborrheic dermatitis. Ketoblink 200 is typically prescribed when topical antifungal treatments are ineffective or impractical. It is important to administer this medication with food to enhance absorption and reduce gastrointestinal discomfort. Patients should adhere strictly to the prescribed dosage and duration to prevent resistance development and ensure therapeutic efficacy. Common side effects may include gastrointestinal disturbances such as nausea, vomiting, and abdominal pain, as well as potential hepatotoxicity; therefore, liver function monitoring is recommended during prolonged therapy. Ketoblink 200 is contraindicated in patients with known hypersensitivity to ketoconazole or other azole antifungals and should be used cautiously in individuals with pre-existing liver disease. Concomitant use with certain drugs metabolized by cytochrome P450 enzymes may result in significant drug interactions; thus, a thorough medication review is essential prior to initiation.